Asuragen to Present at World CB & CDx Europe Summit in London, UK
Asuragen, Inc., a molecular diagnostics company delivering easy to use products for complex testing in genetics and oncology, announced that its senior vice president of commercial operations, Colin Hill, will chair a roundtable discussion during the 2018 World Clinical Biomarkers & Companion Diagnostic (CB & CDx) Europe Summit taking place May 1-3 in London, UK. The session will focus on the imminent changes to the regulatory environment in Europe and the implications for pharmaceutical and diagnostic companies collaborating to advance precision medicine.
“Precision medicine is becoming a reality around the world, and the regulations that guide it are rapidly evolving,” said Hill. “It is essential that we build close collaboration between the pharmaceutical, medical device and in vitro diagnostics industry if we are going to successfully navigate this new environment. While our success will definitely leverage learnings from the US experience, we will have to broaden our thinking as we deal with some of the inherent differences in the healthcare delivery model(s) between the US and Europe.”
The roundtable discussion, titled “The Rx-Dx Paradigm and Ensuring Continued CDx Development with Appropriate Risk and Reward,” is part of the Drug-Dx Commercialisation Stream and will occur at 16.30 on Wednesday, May 2. The discussion will highlight several topical issues facing both the pharmaceutical and diagnostic industries, including addressing value share imbalances between these industries, streamlining the collaboration process from concept to commercialization, and understanding the specific nuances of the European market to ensure mutual successes.
Asuragen is a molecular diagnostic company changing the way patients are treated in genetics and oncology. The quality, simplicity and sensitivity of its products brings precision medicine within reach. Asuragen’s diagnostic systems, composed of proprietary chemistry and software, deliver powerful answers using broadly installed instrument platforms. They are simple to adopt and expand the ability to serve patients. Asuragen is a product foundry rapidly and efficiently addressing current and emerging clinical needs, including cancer diagnosis and monitoring, reproductive health and aging, serving laboratories across a patient’s lifespan with its best in class diagnostic tests. For more information, visit www.asuragen.com.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Milrem Robotics’ THeMIS UGV Strengthens Its Position as The Industry Standard18.2.2019 13:00:00 | Pressemelding
The unmanned warfare systems developer Milrem Robotics is the most represented company in its field at this year’s IDEX with the widest selection of different weaponized unmanned ground systems on display. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190218005105/en/ Together with industry partners MBDA, Electro Optic Systems, ST Engineering and Nexter, Milrem Robotics is exhibiting four different weaponized unmanned ground systems at the main defence event in the Middle East. All systems are integrated onto Milrem Robotics' THeMIS unmanned ground vehicle. (Photo: Business Wire) Together with industry partners MBDA, Electro Optic Systems, ST Engineering and Nexter, Milrem Robotics is exhibiting four different weaponized unmanned ground systems at the main defence event in the Middle East. All systems are integrated onto Milrem Robotics’ THeMIS unmanned ground vehicle. On display are two completely new weaponized UGVs – the
Saudi Arabia Ministry of Health and Masimo Announce Automation of National Neonatal CCHD Screening Process Using Masimo Technology18.2.2019 13:00:00 | Pressemelding
Recently at Arab Health 2019, the Saudi Arabia Ministry of Health (MOH) and Masimo (NASDAQ: MASI) jointly announced the implementation of an automation solution designed to streamline the process of critical congenital heart disease (CCHD) screening of newborns using Masimo SET®, the first automation of its kind worldwide. This latest phase in Saudi Arabia’s national CCHD screening program, which began in 2016 as part of the Vision 2030 plan addressing improvements in healthcare and other areas, automates the collection and storage of screening data, helping to make the process both more efficient and more accurate. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190218005021/en/ Masimo Rad-97™ with Eve™ (Photo: Business Wire) In 2016, Saudi Arabia implemented a mandatory CCHD screening program for all newborns using the Masimo Eve™ Newborn Screening Application on Radical-7® Pulse CO-Oximeters® with SET® Measure-through Moti
Third-Party Study Validates STATS K50 GPS’ Superior Accuracy in Measuring High-Intensity Performance18.2.2019 07:00:00 | Pressemelding
In a recent independent study by the Technical University of Munich (TUM), STATS, the worldwide leader in sports data and intelligence, had its novel 50 Hz GPS system (STATS K50) tested against a traditional 15 Hz GPS system (GPSports SpiProX) to measure covered distance and instantaneous velocity. Both systems were simultaneously recorded and measured against a criterion reference (Laveg radar gun) during 30-metre linear sprint trials. The study, commissioned by STATS and conducted by TUM, found that STATS K-50 has a smaller bias than a traditional technology and that it is capable of quantifying high intensity activities 30% more accurately. High-intensity movements and accelerated runs over short distances are believed to be the most important variables to be tracked in sports science. STATS K50’s new approach to wearable tracking is an integrated inertial navigation system (INS)/GPS technology that combines 50 Hz GPS position and Doppler velocity measurements with inertial measurem
Electric Motor Company YASA Signs Innovation Agreement with Global Automotive Manufacturer18.2.2019 06:05:00 | Pressemelding
YASA, the world’s leading manufacturer of axial-flux electric motors and controllers, today announced signing a long-term joint innovation agreement with a global automotive OEM. The partnership will focus on developing custom electric motor and controller solutions for the OEM’s high-performance hybrid and pure electric vehicles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190217005021/en/ YASA axial-flux electric motor (segmented) (Photo: Business Wire) YASA’s innovative axial-flux electric motor and controller designs offer best-in-class power and torque densities and are ideally suited to both hybrid and pure electric vehicle applications. Under the agreement, YASA and the OEM will work together to leverage YASA’s technology to improve vehicle performance whilst reducing vehicle weight. This news follows YASA’s announcement last year of a new 100,000 unit capacity series production facility in Oxford, UK. In addition
Chinese Tourists Propel Alipay’s Overseas Growth during the 2019 Lunar New Year18.2.2019 04:50:00 | Pressemelding
Alipay today announces additional statistics that reveal more about the overseas spending and mobile payment behavior of Chinese consumers during the 2019 Lunar New Year period. The data has been drawn from the 54 markets where Alipay is accepted. Combined with the preliminary findings released on Feb 11, the statistics provide a unique way to measure the pulse of China’s vibrant consumer and tourism markets. Key findings between February 4- 10 reveal: Both transaction values and volumes experienced robust growth Offline in-store transaction value surged 2.2 times year-on-year Europe dominates the top 10 countries in terms of average spend Top five countries that saw the highest growth on average spend were: Denmark (22.7 times), Spain (7.1 times), The Philippines (5 times), Belgium (4.7 times) and Switzerland (3.4 times) Asian claims nine out of top 10 countries by transaction volumes with the exception of Canada, which climbed to tenth spot due to increased adoption by local merchant
IFF Recognized by SAM’s 2019 “Industry Mover” Sustainability Award15.2.2019 21:15:00 | Pressemelding
Regulatory News: International Flavors & Fragrances Inc. (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF), was recognized for its sustainability efforts with the 2019 “Industry Mover” award from SAM, a subsidiary of RobecoSAM which specializes in providing environmental, social and governance (ESG) data, benchmarks and ratings. The recognition acknowledges the Company’s top-scoring performance in economic, social and environmental categories. “We are thrilled to receive this award from SAM,” said Andreas Fibig, IFF Chairman & CEO. “Our sustainability efforts are not only a key enabler of our overall strategy, but also a true passion here at IFF -- and we place it at the forefront of everything we do. It is deeply gratifying to have our work and our people recognized for doing the right thing for the planet.” SAM’s 2019 scoring is based on its 2018 Corporate Sustainability Assessment. Using a weighted methodology, SAM evaluates companies for criteria such as: codes of business conduct, ope